Amgen's TPO mimic faces stiff competition.
Lawrence
Stacy
S
D002352:Carrier Proteins / Q000627:therapeutic use*; D004345:Drug Industry / Q000458:organization & administration*; D004465:Economic Competition / Q000458:organization & administration*; D006402:Hematologic Diseases / Q000188:drug therapy*; D006801:Humans; D011961:Receptors, Fc / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; D014481:United States
D002352:Carrier Proteins; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim